VIRCHOWS ARCHIV

VIRCHOWS ARCHIV

VIRCHOWS ARCH
影响因子:3.1
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:GERMANY
出版社:Springer Berlin Heidelberg
发刊时间:1847
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:0945-6317

期刊介绍

Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.
欢迎使用免疫细胞化学、分子和超微结构技术加强现代诊断病理学证据基础的原创研究手稿。此外,还将考虑关于诊断标准批判性评价的论文,以及具有坚实证据基础的大报和指南。还将考虑与理解人类病理学有关的其他领域的工作报告以及关于病理学新方法和新技术应用的手稿。不鼓励提交纯实验性文章,但欢迎提交适用于诊断病理学的实验性工作的手稿。生物标志物研究是受欢迎的,但需要遵守足够样本量和相关标志物选择的严格规则(例如REMARK)。通常不考虑对有限患者系列进行的未经验证的单标记物研究。仅当病例报告提供了对理解疾病或诊断实践有影响的实质性新信息时,才会考虑病例报告。
年发文量 245
国人发稿量 15.61
国人发文占比 0.06%
自引率 -
平均录取率0
平均审稿周期 偏慢,4-8周
版面费 US$4190
偏重研究方向 医学-病理学
期刊官网 https://www.springer.com/428
投稿链接 https://www.editorialmanager.com/viar

期刊高被引文献

IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02571-3
The spectrum of myocarditis: from pathology to the clinics
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02615-8
Invited review—next-generation sequencing: a modern tool in cytopathology
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02559-z
Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02710-w
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02610-z
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02624-7
Low-grade endometrial stromal sarcoma with a novel MEAF6-SUZ12 fusion
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02588-8
Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02626-5
State of the art in post-mortem computed tomography: a review of current literature
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02562-4
The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02568-y
PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02582-0
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02528-6
What’s new in bone forming tumours of the skeleton?
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02683-w
Immune cell score in pancreatic cancer—comparison of hotspot and whole-section techniques
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02549-1
Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02636-3
Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02684-9
Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02704-8
Dataset for the reporting of prostate carcinoma in radical prostatectomy specimens: updated recommendations from the International Collaboration on Cancer Reporting
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02574-0
COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02553-5
What is new in endothelial neoplasia?
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02651-4
Atypical goblet cell hyperplasia occurs in CPAM 1, 2, and 3, and is a probable precursor lesion for childhood adenocarcinoma
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02732-4
Small-bowel carcinomas associated with celiac disease: transcriptomic profiling shows predominance of microsatellite instability-immune and mesenchymal subtypes
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02675-w
Non-conventional mucosal lesions (serrated epithelial change, villous hypermucinous change) are frequent in patients with inflammatory bowel disease—results of molecular and immunohistochemical single institutional study
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02627-4
Solitary fibrous tumor: a case series identifying pathological adverse factors—implications for risk stratification and classification
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02660-3
Spindle cell liposarcoma with a TRIO-TERT fusion transcript
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02545-5
Targeted RNA-sequencing identifies FBXW4 instead of MGEA5 as fusion partner of TGFBR3 in pleomorphic hyalinizing angiectatic tumor
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02556-2
What’s new in fibroblastic tumors?
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02682-x
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02573-1
Prognostic impact of intra-field heterogeneity in oral squamous cell carcinoma
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02656-z
Prognostic significance of combining immunohistochemical markers for cancer-associated fibroblasts in lung adenocarcinoma tissue
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02587-9
Epstein-Barr virus is absent in gastric superficial neoplastic lesions
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02670-1
Transient receptor potential vanilloid (TRPV) channel expression in meningiomas: prognostic and predictive significance
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02584-y
The subgross morphology of breast carcinomas: a single-institution series of 2033 consecutive cases documented in large-format histology slides
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02641-6
Immunohistochemical analysis of the expression of cancer-associated fibroblast markers in esophageal cancer with and without neoadjuvant therapy
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02714-6
Synoptic reporting increases quality of upper gastrointestinal cancer pathology reports
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02586-w
Correction to: Abstracts
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02688-5
The broad and challenging landscape of extranodal lymphoproliferations
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02702-w
Robust expression of EZH2 in endocervical neoplastic lesions
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02550-8
Assessment of two different HER2 scoring systems and clinical relevance for colorectal cancer
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02668-9
Acknowledgement to reviewers 2018
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02537-5
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02696-5
Book Review—Diagnostic pathology: placenta, second edition
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02581-1
Cell-to-cell variation of chromosomal number in the adult testicular germ cell tumors: a comparison of chromosomal instability among histological components and its putative role in tumor progression
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02560-6
Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02600-1
Gestational trophoblastic neoplasms (GTNs) do not display epithelial-to-mesenchymal transition (EMT) features
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02551-7
Incidental lymphoma in lymph node dissection for carcinoma in the abdominopelvic cavity: a single-institution experience
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02578-w
In this issue
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02721-7
Abstracts
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02631-8
In this issue
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02669-8
Compact buds with biphasic differentiation and calcitonin-expressing neuroendocrine cells—previously unrecognized structures of thyroglossal duct unveiled by immunohistochemistry
来源期刊:Virchows ArchivDOI:10.1007/s00428-019-02536-6

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
87.76%40.78%-5.76%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PATHOLOGY
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学2区
PATHOLOGY 病理学
2区
2023年12月升级版
医学3区
PATHOLOGY 病理学
2区
2022年12月旧的升级版
医学3区
PATHOLOGY 病理学
2区